CTOs on the Move

Excision BioTherapeutics

www.excision.bio

 
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.excision.bio
  • 988 Market Street
    San Francisco, CA USA 94102
  • Phone: 404.229.1162

Executives

Name Title Contact Details
Franz Gerner
Chief Technology Officer Profile

Funding

Excision BioTherapeutics raised $60M on 02/17/2021

Similar Companies

Myriant Technologies

At Myriant, we know there`s a better, greener way to produce the products people use every day. And we`re realizing that vision—displacing barrels of petroleum by manufacturing and selling high-value chemicals made from renewable, sustainable feedstocks. As companies and consumers look for ways to reduce their carbon footprint and transition away from petroleum`s price volatility, Myriant has the solution: our proven technology platform and strategic feedstock selection enable Myriant to deliver high-quality, high-performing, green chemicals at a competitive, more-predictable cost versus petroleum-based chemicals without the need for government subsidies. That`s what we call a sustainable advantage.

BioCaptiva

Use this space to add a brief description of your project.

Kamiya Biomedical Company

Kamiya Biomedical Company is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Valo Health

Valo Health is a biotech company that is recreating the future of medicine.

Dow Pharmaceutical Sciences

Dow Pharmaceutical Sciences is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.